CD40 and neoplasm: We then examine the evidence supporting an immune-based vaccine therapy that utilizes mannan-BAM, TLR Ligands, anti-CD40 antibody (MBTA) to induce both an innate and adaptive immune response to tumor cells as a potential treatment specifically for GBM.